Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SCMBench: benchmarking domain-specific and foundation models for single-cell multi-omics data integration.

Nature communications·2026
Same author

An effective encoding of human medical conditions in disease space provides a versatile framework for deciphering disease associations.

Quantitative biology (Beijing, China)·2026
Same author

Longitudinal analysis of electronic health records reveals medical conditions associated with subsequent Alzheimer's disease development.

Alzheimer's research & therapy·2025
Same author

<sup>1</sup>H NMR-Based Quantitative Lipoprotein Measurement Cross-Validation with Enzymatic Methods Applied to the OMNI-Heart Dietary Intervention Study.

Journal of proteome research·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

SCREAM: Single-cell Clustering using Representation Autoencoder of Multiomics.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jun 2, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Parameter estimation of kinetic models from metabolic profiles: two-phase dynamic decoupling method.

Gengjie Jia1, Gregory N Stephanopoulos, Rudiyanto Gunawan

  • 1Chemical and Pharmaceutical Engineering, Singapore-MIT Alliance, Singapore 117576.

Bioinformatics (Oxford, England)
|May 12, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces an iterative method for estimating kinetic parameters in metabolic models. The approach efficiently handles incomplete and noisy time-course data, improving model accuracy.

More Related Videos

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR
10:54

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR

Published on: February 23, 2016

Related Experiment Videos

Last Updated: Jun 2, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR
10:54

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR

Published on: February 23, 2016

Area of Science:

  • Systems Biology
  • Metabolic Engineering
  • Computational Biology

Background:

  • Time-series metabolite data are crucial for building kinetic models of metabolic networks using ordinary differential equations (ODEs).
  • Estimating kinetic parameters from incomplete and noisy time-course data presents significant challenges.
  • Existing methods face limitations due to data scarcity, noise, stiff ODEs, and global optimization difficulties.

Purpose of the Study:

  • To develop a novel, robust parameter estimation procedure for metabolic models.
  • To circumvent practical limitations associated with incomplete data and computational complexity.
  • To improve the accuracy and efficiency of kinetic parameter estimation.

Main Methods:

  • An incremental and iterative parameter estimation method combining two phases.
  • Phase 1: Decoupling method estimating parameters linked to measured metabolites via slope error minimization.
  • Phase 2: Sequential ODE solving to estimate remaining parameters by minimizing concentration errors.

Main Results:

  • The proposed two-phase method demonstrated efficiency in parameter estimation.
  • Accurate kinetic parameter estimates were achieved even with missing data.
  • Performance validated on a generic branched metabolic pathway and the glycolytic pathway of Lactococcus lactis.

Conclusions:

  • The developed method provides an effective solution for estimating kinetic parameters from challenging metabolic data.
  • It offers a practical approach to overcome limitations in data availability and computational demands.
  • The method enhances the reliability of kinetic models for metabolic engineering and systems biology applications.